Previous 10 | Next 10 |
Are These 4 High Volume Penny Stocks on Your Watchlist? Finding penny stocks with high volume is a great way to stay ahead in the market. While high-volume penny stocks are by no means the only ones worth watching, they can present interesting opportunities to investors. One of the ...
3 Penny Stocks For Your End of July Watchlist With July coming to an end, many penny stocks investors are ready to hit the reset button. While a new month is nothing more than symbolic for the stock market, this could be enough to put us on a bullish trajectory. Right now, there are a s...
Gainers: Tyme Technologies (TYME) +64%.Bit Digital (BTBT) +49%.SPAR Group (SGRP) +41%.Xenetic Biosciences (XBIO) +26%.IMV (IMV) +25%.Studio City International Holdings (MSC) +25%.Bitfarms (BITF) +24%.MicroStrategy (MSTR) +22%.Riot Blockchain (RIOT) +21%.RBC Bearings (ROLL) +19%.Losers: Iterum...
Mikhail Leonov/iStock via Getty Images The week got started with another round of earnings reports before the bell Monday. Hasbro (HAS), Philips (PHG) and Lockheed Martin (LMT) all reported their quarterly results. In non-earnings news, SPX Flow (FLOW) revealed that it is considering "strateg...
Iterum Therapeutics plc (ITRM) -43% after announcing FDA’s Complete Response Letter for sulopenem.ATI Physical Therapy, Inc. (ATIP) -25% on Q2 earnings releaseNew Oriental Education & Technology Group Inc. (EDU) -24% provides update on new regulations.China...
Grandbrothers/iStock Editorial via Getty Images Iterum Therapeutics (ITRM) has lost ~42.7% in early trading after announcing that the FDA has issued a Complete Response Letter ((CRL)) for the marketing application of sulopenem etzadroxil/probenecid (oral sulopenem). With PDUFA ...
DUBLIN, Ireland and CHICAGO, July 26, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant patho...
India Globalization Capital (IGC) +128% announces issuance of Patent for the treatment of Alzheimer’s disease using THCPainReform (PRFX) +51%.ImmunoPrecise Antibodies IPA +41% highlights new data from TATX-03 SARS-CoV-2 Delta studySequential Brands (SQBG) +28%.NeuroMetri...
3 Top Penny Stocks For Your Summer Watchlist With summer more than halfway done, penny stocks continue to be the talk of the town. Despite a few months of less than stellar trading with both penny stocks and blue chips , there are plenty of opportunities to be had. On Friday, tr...
naphtalina/iStock via Getty Images COVID-19-related headlines dominated the holiday-shortened week as the Delta variant of the virus renewed pandemic fears across the globe. Meanwhile, with a ~1.3% gain over the past five-day period, the S&P 500 Healthcare Index outper...
News, Short Squeeze, Breakout and More Instantly...
Iterum Therapeutics plc Company Name:
ITRM Stock Symbol:
NASDAQ Market:
Iterum Therapeutics plc Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
DUBLIN, Ireland and CHICAGO, June 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community...
DUBLIN and CHICAGO, June 05, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hosp...